Frec Markets, Inc.

Position in NBIX — Neurocrine Biosciences Inc

CIK 2111359 SAN FRANCISCO, CA

Position in NBIX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$490,468

New position

Shares Held

3,723

first reported quarter

Ownership

0.004%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Frec Markets, Inc. holds $1,915,041 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (25.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	3,723	$490,468
2	UTHR	UNITED THERAPEUTICS Corp	539	$319,616
3	VTRS	Viatris Inc	19,415	$262,296
4	ZTS	Zoetis Inc.	2,065	$244,103
5	DERM	Journey Medical Corp	50,500	$236,845
6	TAK	Takeda Pharmaceutical Co Ltd	11,530	$213,535
7	HLN	Haleon plc	14,803	$148,178

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$490,468	3,723	—	Shares	Defined	2026-05-14
No filing history on record for this holder in this stock.